尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Bunnage Mark E.. Insider active across 1 company, notably VERTEX PHARMACEUTICALS INC / MA. Aggregated, 4 reports have been recorded. History available since 10 February 2026. The latest transaction was disclosed on 24 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
A declarant linked to VERTEX PHARMACEUTICALS INC / MA has filed 4 forms in total. In the recent filings observed between 2026-02-12 and 2026-02-26, the most frequent transaction nature is Tax withholding, and the published principal amounts include EUR 938248.9976761341 on 2026-02-18, EUR 443460.7603710371 on 2026-02-12, and EUR 239391.0177068839 on 2026-02-26.